News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Ceritinib shows therapeutic potential in ALK-positive nonsmall cell lung cancer
21 Jun 2022
The anaplastic lymphoma kinase (ALK) inhibitor ceritinib delivers favourable antitumour activity in ALK-mutated nonsmall cell lung cancer (NSCLC) patients with active brain metastases and/or leptomeningeal disease, according to the phase II ASCEND-7 trial.
21 Jun 2022

Bimekizumab triumphs in bDMARD-naïve psoriatic arthritis patients
20 Jun 2022
byRoshini Claire Anthony
Patients with psoriatic arthritis (PsA) with no prior exposure to biological disease-modifying antirheumatic drugs (bDMARDs) experience improvements in their condition when treated with bimekizumab, according to results of the phase III BE OPTIMAL trial.
20 Jun 2022

Insulin resistance tied to atherogenic lipoprotein/lipid, cIMT in obese youths
20 Jun 2022
Insulin resistance in young people with obesity is positively associated with an atherogenic lipoprotein/lipid profile and carotid intima-media thickness (cIMT), regardless of their glucose tolerance status, suggests a study.
20 Jun 2022





